Viva Biotech (1873) Announces Board Composition and Committee Membership
Bulletin Express
Feb 16
Viva Biotech Holdings released an announcement detailing its board of directors and committee assignments. The board comprises three executive directors (Mr. Mao Chen Cheney as Chairman, Mr. Wu Ying, and Mr. Ren Delin), one non-executive director (Mr. Wu Yuting), and three independent non-executive directors (Mr. Fu Lei, Ms. Li Xiangrong, and Mr. Wang Haiguang).
Mr. Mao serves as Chairman of the Nomination Committee. Mr. Fu, Ms. Li, and Mr. Wang serve as members of both the Audit Committee and the Remuneration Committee. Ms. Li chairs the Audit and Remuneration Committees, and Mr. Fu is also a member of the Nomination Committee.
The announcement was published on February 16, 2026, in Hong Kong.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.